North America Histopathology Services Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Histopathology Services Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Histopathology Services Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Histopathology Services Market Regional Analysis

6.2 North America Histopathology Services Market Revenue 2019-2028 (US$ Million)

6.3 North America Histopathology Services Market Forecast Analysis

7. North America Histopathology Services Market Analysis – by Type of Examination

7.1 Surgical Specimen

7.1.1 Overview
7.1.2 Surgical Specimen: North America Histopathology Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Breast Biopsy

7.2.1 Overview
7.2.2 Breast Biopsy: North America Histopathology Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Lung Biopsy

7.3.1 Overview
7.3.2 Lung Biopsy: North America Histopathology Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.4 Renal Biopsy

7.4.1 Overview
7.4.2 Renal Biopsy: North America Histopathology Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.5 Gastrointestinal Biopsy

7.5.1 Overview
7.5.2 Gastrointestinal Biopsy: North America Histopathology Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.6 Pancreatic Biopsy

7.6.1 Overview
7.6.2 Pancreatic Biopsy: North America Histopathology Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.7 Skin Tissue Biopsy

7.7.1 Overview
7.7.2 Skin Tissue Biopsy: North America Histopathology Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.8 Testicular Biopsy

7.8.1 Overview
7.8.2 Testicular Biopsy: North America Histopathology Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Histopathology Services Market Analysis – by End User

8.1 Diagnostic Laboratories & Reference Laboratories

8.1.1 Overview
8.1.2 Diagnostic Laboratories & Reference Laboratories: North America Histopathology Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Research Institutes

8.2.1 Overview
8.2.2 Research Institutes: North America Histopathology Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Histopathology Services Market – North America Analysis

9.1 Overview

9.2 North America

9.2.1 North America Histopathology Services Market Breakdown, by Key Country, 2022 and 2028 (%)
9.2.1.1 North America Histopathology Services Market – Revenue and Forecast Analysis – by Country
9.2.1.1 US: North America Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.1.1 US: North America Histopathology Services Market Breakdown, by Type of Examination
9.2.1.1.2 US: North America Histopathology Services Market Breakdown, by End User

9.2.1.2 Canada: North America Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.2.1 Canada: North America Histopathology Services Market Breakdown, by Type of Examination
9.2.1.2.2 Canada: North America Histopathology Services Market Breakdown, by End User

9.2.1.3 Mexico : North America Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.3.1 Mexico : North America Histopathology Services Market Breakdown, by Type of Examination
9.2.1.3.2 Mexico : North America Histopathology Services Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Sonic Healthcare Limited

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Laboratory Corporation of America Holdings

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 TPL Path Labs

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Cureline Global Translational CRO

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Targos

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Experimental Pathology Laboratories Inc (EPL)

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 CHARLES RIVER LABORATORIES, INC.

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

North America Histopathology Services Market

Analysis By Type of Examination (Surgical Specimen, Breast Biopsy, Lung Biopsy, Renal Biopsy, Gastrointestinal Biopsy, Pancreatic Biopsy, Skin Tissue Biopsy, Testicular Biopsy, and Others) and End User (Diagnostic Laboratories & Reference Laboratories, Research Institutes, and Others)